What does commercial auto liability — year 5 mean?

This metric tracks the financial performance of the commercial auto liability insurance product line in the fifth year. It captures the revenue contribution from policies covering legal liabilities arising from commercial vehicle operations. Analyzing this data point allows for the evaluation of year-over-year segment performance and market penetration.

King Pharmaceuticals KG Commercial Auto Liability — Year 5

Other product segments

General Liability

14%—

European Hospital Liability

11.9%—

All other lines

3.6%—

International

-0.8%—

Similar metrics at other companies

CNACommercial Auto — Year 5

10.7%+0.2pp

KMPRCommercial Automobile Insurance—Liability — Year 5

91.6%+1.1pp

UFCSCommercial automobile — Year 5

7.8%+0.1pp

ORICommercial Automobile — Year 5

6.5%+0.1pp

KMPRCommercial Automobile Insurance—Physical Damage — Year 5

100%0.0pp

UFCSCommercial other liability — Year 5

10.2%-1.0pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's commercial auto liability — year 5.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's commercial auto liability — year 5?: King Pharmaceuticals (KG) reported commercial auto liability — year 5 of 14% in Q4 2025.
What does commercial auto liability — year 5 mean?: This metric tracks the financial performance of the commercial auto liability insurance product line in the fifth year. It captures the revenue contribution from policies covering legal liabilities arising from commercial vehicle operations. Analyzing this data point allows for the evaluation of year-over-year segment performance and market penetration.